MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01149nam a2200289#i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
0000016880 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
NIH |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240220144541.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240220s2010 xx 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789241209571 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
IMR |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV771 |
| Item number |
who 2010 |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Specifications for Pharmaceutical Preparations |
| Relator term |
issuing body. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
WHO Expert Committee on Specifications for Pharmaceutical Preparations: |
| Remainder of title |
forty-fourth report |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Geneva: |
| Name of producer, publisher, distributor, manufacturer |
World Health Organization, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2010 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xi, 276 pages; |
| Dimensions |
24cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
WHO technical report series |
| Volume/sequential designation |
937 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization |
| 650 10 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Industry |
| General subdivision |
standards |
| 650 20 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical Preparations |
| General subdivision |
standards |
| 710 ## - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization |
| 830 ## - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
World Health Organization technical report series |
| Volume/sequential designation |
957 |